INNOVATE Corp. (VATE) Bundle
A Brief History of INNOVATE CORP.
INNOVATE CORP., traded under the ticker symbol VATE on the New York Stock Exchange, has undergone significant transformations and financial maneuvers leading into 2024. The company was established to focus on innovative solutions across various sectors, including life sciences and infrastructure.
Recent Financial Developments
As of September 30, 2024, INNOVATE reported a net loss of $16.2 million for the quarter, compared to a loss of $8.6 million during the same period in 2023. For the nine months ended September 30, 2024, the cumulative net loss was $22.4 million, down from $28.3 million in 2023.
Stock Performance and Shareholder Actions
On June 18, 2024, shareholders approved the conversion of approximately 31,286 shares of Series C Preferred Stock, which were held by Lancer Capital, into 4,469,390 shares of common stock. This conversion was part of a broader strategy to restructure the company's equity following a 1-for-10 reverse stock split on August 8, 2024, aimed at regaining compliance with NYSE listing requirements.
Capital Raising Initiatives
In March 2024, INNOVATE launched a $19.0 million rights offering, which was backstopped by Lancer Capital. The offering allowed existing shareholders to purchase additional shares at a conversion price of $0.70 per share (pre-reverse split basis). The company also raised an additional $16.0 million through a private placement of Series C Preferred Stock.
Balance Sheet Overview
As of September 30, 2024, INNOVATE reported total assets of $897.2 million, a decrease from $1,043.6 million as of December 31, 2023. The decrease was attributed to various asset sales and operational challenges. The total liabilities stood at $690.9 million, with a significant portion allocated to debt obligations.
| Financial Metric | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Total Assets | $897.2 million | $1,043.6 million |
| Total Liabilities | $690.9 million | $615.7 million |
| Net Loss (Quarter) | $16.2 million | $8.6 million |
| Net Loss (Year-to-Date) | $22.4 million | $28.3 million |
| Common Shares Outstanding | 13,261,379 | 7,923,500 |
Corporate Governance and Strategic Direction
INNOVATE's governance structure saw changes as the company focused on enhancing shareholder value. The termination of the Tax Benefits Preservation Plan on May 6, 2024, was a strategic decision made by the board to streamline operations and reduce administrative overhead.
Future Outlook
Looking forward, INNOVATE aims to leverage the proceeds from its recent capital raises for general corporate purposes, including debt servicing and working capital needs. The company is expected to focus on optimizing its asset portfolio and enhancing operational efficiencies to drive future growth.
A Who Owns INNOVATE Corp. (VATE)
Shareholder Composition
As of September 30, 2024, the total number of shares outstanding for INNOVATE Corp. was 13,166,057, following a 1-for-10 reverse stock split that occurred on August 8, 2024.
Major Shareholders
The following table outlines the major shareholders and their respective ownership percentages:
| Shareholder | Type of Ownership | Number of Shares Owned | Ownership Percentage |
|---|---|---|---|
| Lancer Capital LLC | Institutional Investor | 4,469,390 | 34.0% |
| Avram A. Glazer | Individual Investor | 1,000,000 (approx.) | 7.6% |
| Other Institutional Investors | Various | 7,696,667 (approx.) | 58.4% |
Institutional Ownership
As of the same date, institutional investors collectively owned approximately 58.4% of the company’s shares, indicating a strong interest from larger investment entities.
Recent Share Transactions
In April 2024, INNOVATE completed a Rights Offering, issuing approximately 530,611 shares of common stock for $3.7 million, which was part of an effort to raise capital. This offering was crucial for managing debt and enhancing liquidity.
Convertible Notes and Preferred Shares
As of September 30, 2024, Lancer Capital held $2.0 million of the company’s 2026 Convertible Notes, convertible into approximately 47,265 shares of common stock. Additionally, the company had previously issued Series C Preferred Stock, which was converted into common stock upon shareholder approval.
Shareholder Rights and Agreements
INNOVATE Corp. has a Tax Benefits Preservation Plan designed to protect its net operating loss carryforwards from being limited due to ownership changes. This plan allows certain shareholders to acquire additional shares without triggering adverse tax consequences.
Financial Overview
As of September 30, 2024, INNOVATE Corp. reported total liabilities of $897.2 million and a stockholders' deficit of $141.1 million. The financial landscape reflects challenges in operational profitability, with a net loss attributable to common stockholders of $15.3 million for the quarter ending September 30, 2024.
Conclusion of Ownership Structure
The ownership structure of INNOVATE Corp. is heavily influenced by institutional interests, notably Lancer Capital, which plays a pivotal role in the company’s capital structure and governance. The evolving financial dynamics and ongoing capital efforts will be critical for stakeholders monitoring the company's trajectory in 2024 and beyond.
INNOVATE Corp. (VATE) Mission Statement
Company Overview
INNOVATE Corp. (VATE) operates across multiple sectors including Infrastructure, Life Sciences, and Spectrum services. The company aims to drive innovation and efficiency across these sectors through advanced technologies and sustainable practices.
Mission Statement
As of 2024, INNOVATE Corp.'s mission is to enhance the quality of life through innovative solutions that address critical challenges in various industries. The company is committed to sustainability, operational excellence, and delivering value to its stakeholders.
Financial Performance Metrics
The following table summarizes key financial metrics related to INNOVATE Corp. as of September 30, 2024:
| Metric | Value (in millions) |
|---|---|
| Revenue (Q3 2024) | $242.2 |
| Gross Profit (Q3 2024) | $48.2 |
| Net Loss (Q3 2024) | $(15.0) |
| Adjusted EBITDA (Q3 2024) | $16.8 |
| Net Income (Loss) (9M 2024) | $(18.0) |
Segment Performance
INNOVATE Corp. segments its operations into Infrastructure, Life Sciences, and Spectrum. Below are the financial results for each segment for the three months ended September 30, 2024:
| Segment | Net Income (Loss) (in millions) | Adjusted EBITDA (in millions) |
|---|---|---|
| Infrastructure | $6.2 | $20.9 |
| Life Sciences | $(6.0) | $(3.0) |
| Spectrum | $(5.6) | $1.7 |
| Non-Operating Corporate | $(9.6) | $(2.8) |
Market Position and Strategy
INNOVATE Corp. has positioned itself as a leader in the innovation space by focusing on sustainable practices and leveraging advanced technology. The company aims to expand its market share through strategic partnerships, enhancing its product offerings, and optimizing operational efficiency.
Stakeholder Engagement
INNOVATE Corp. emphasizes transparency and engagement with its stakeholders, including investors, employees, and customers. The company is committed to corporate social responsibility and actively seeks feedback to improve its services and operations.
Future Outlook
Looking ahead, INNOVATE Corp. plans to invest in research and development to further enhance its product lines and maintain its competitive edge in the market. The focus will be on driving innovation that aligns with the mission of improving quality of life through technology.
Recent Developments
In 2024, INNOVATE Corp. completed a Rights Offering, raising $35.0 million for general corporate purposes, including debt service and working capital . The company also undertook a reverse stock split to enhance its stock price .
How INNOVATE Corp. (VATE) Works
Overview of Financial Performance
As of September 30, 2024, INNOVATE Corp. reported a revenue of $242.2 million for the third quarter, a decrease from $375.3 million in the same period of the previous year. For the nine months ended September 30, 2024, revenue totaled $870.5 million, down from $1,062.0 million in 2023.
Segment Performance
The decline in revenue was primarily driven by the Infrastructure segment, while the Life Sciences and Spectrum segments showed growth. The table below summarizes the Adjusted EBITDA by segment for the three months ended September 30, 2024 and 2023.
| Segment | Adjusted EBITDA (Q3 2024) | Adjusted EBITDA (Q3 2023) | Increase/Decrease |
|---|---|---|---|
| Infrastructure | $20.9 million | $30.8 million | $(9.9 million) |
| Life Sciences | $(3.0 million) | $(4.3 million) | $1.3 million |
| Spectrum | $1.7 million | $(0.3 million) | $2.0 million |
| Non-Operating Corporate | $(2.8 million) | $(4.1 million) | $1.3 million |
| Overall Adjusted EBITDA | $16.8 million | $22.1 million | $(5.3 million) |
Income Statement Highlights
For the three months ended September 30, 2024, INNOVATE Corp. recorded a net loss of $(16.2 million), compared to a net loss of $(8.6 million) in the same quarter of 2023. The detailed income statement for Q3 2024 is as follows:
| Item | Q3 2024 | Q3 2023 |
|---|---|---|
| Revenue | $242.2 million | $375.3 million |
| Cost of Revenue | $194.0 million | $316.6 million |
| Gross Profit | $48.2 million | $58.7 million |
| Selling, General & Administrative Expenses | $37.4 million | $43.8 million |
| Net Loss | $(16.2 million) | $(8.6 million) |
Debt Management
As of September 30, 2024, INNOVATE Corp. had a maximum commitment of $20.0 million on its Revolving Line of Credit with MSD PCOF Partners IX, LLC, which was fully drawn. The maturity date for this line of credit is May 16, 2025, with an interest rate margin of 5.75%.
The company also has $330.0 million in aggregate principal amount of 8.50% senior secured notes due February 1, 2026. Interest expense related to these notes was $7.6 million for Q3 2024.
Stockholder Equity
As of September 30, 2024, INNOVATE Corp. reported total stockholders' deficit of $(141.1 million). The breakdown of stockholders' equity is as follows:
| Component | Amount |
|---|---|
| Common Stock | $0.1 million |
| Additional Paid-In Capital | $348.4 million |
| Treasury Stock | $(5.4 million) |
| Accumulated Deficit | $(505.3 million) |
| Accumulated Other Comprehensive Loss | $(0.8 million) |
| Total Stockholders' Deficit | $(141.1 million) |
Cash Flow Analysis
As of September 30, 2024, cash and cash equivalents stood at $51.0 million, down from $80.8 million at the end of 2023. The decline is attributed to operational cash flow challenges and ongoing investments in working capital.
Recent Financing Activities
INNOVATE Corp. completed a Rights Offering which generated $35.0 million in gross proceeds. This included $31.3 million from Lancer Capital. The proceeds are being utilized for general corporate purposes including debt service and working capital needs.
As part of the Rights Offering, INNOVATE redeemed $4.1 million of CGIC Unsecured Notes on April 26, 2024, reflecting strategic management of its debt obligations.
Conclusion of Financial Position
As of September 30, 2024, INNOVATE Corp. continues to navigate a challenging financial landscape with significant operational losses, but is actively managing its debt and equity financing to support ongoing operations and future growth initiatives.
How INNOVATE Corp. (VATE) Makes Money
Revenue Streams
INNOVATE Corp. generates revenue primarily through its three business segments: Infrastructure, Life Sciences, and Spectrum. For the nine months ending September 30, 2024, the company reported total revenue of $870.5 million, a decrease from $1,062.0 million for the same period in 2023.
| Segment | Revenue (2024) | Revenue (2023) | Change |
|---|---|---|---|
| Infrastructure | $845.9 million | $1,043.4 million | $(197.5 million) |
| Life Sciences | $5.7 million | $1.8 million | $3.9 million |
| Spectrum | $18.9 million | $16.8 million | $2.1 million |
| Total Revenue | $870.5 million | $1,062.0 million | $(191.5 million) |
Infrastructure Segment
The Infrastructure segment remains the largest contributor to INNOVATE's revenue. The decrease in revenue for this segment was primarily due to the timing and size of projects, particularly in commercial structural steel fabrication and erection. As of September 30, 2024, DBMG's backlog stood at $916.1 million, with approximately $418.0 million (45.6%) attributable to five major contracts.
Life Sciences Segment
The Life Sciences segment reported an increase in revenue attributed to R2 Technologies, which saw a rise in sales of its products, including Glacial fx systems and consumables. This segment recorded a net loss of $14.3 million for the nine months ended September 30, 2024, compared to a loss of $9.3 million in the same period of 2023.
Spectrum Segment
The Spectrum segment, which focuses on network launches and expanded coverage, showed a modest increase in revenue, reflecting growth in operational capabilities and customer relationships.
Operating Expenses
INNOVATE Corp. incurred a total cost of revenue of $708.1 million for the nine months ended September 30, 2024, resulting in a gross profit of $162.4 million. Operating expenses, including selling, general and administrative costs, totaled $119.8 million for the same period.
| Expense Type | Amount (2024) | Amount (2023) |
|---|---|---|
| Cost of Revenue | $708.1 million | $907.1 million |
| Gross Profit | $162.4 million | $154.9 million |
| Selling, General and Administrative Expenses | $119.8 million | $126.6 million |
Net Loss and Adjusted EBITDA
Despite revenue generation, INNOVATE Corp. reported a net loss of $22.4 million for the nine months ended September 30, 2024, compared to a loss of $28.3 million for the same period in 2023. Adjusted EBITDA for the nine months was $56.3 million, an increase from $43.5 million year-over-year.
| Metric | Amount (2024) | Amount (2023) |
|---|---|---|
| Net Loss | $(22.4 million) | $(28.3 million) |
| Adjusted EBITDA | $56.3 million | $43.5 million |
Debt and Interest Expenses
INNOVATE Corp. faces significant interest expenses, amounting to $54.9 million for the nine months ended September 30, 2024, compared to $49.0 million in 2023. The company has a Revolving Line of Credit of $20.0 million, fully drawn as of September 30, 2024.
Liquidity Position
As of September 30, 2024, INNOVATE Corp. reported cash and cash equivalents of $51.0 million, a decrease from $80.8 million at the end of 2023. This liquidity is crucial for meeting operational needs and servicing debt obligations.
| Liquidity Metric | Amount (2024) | Amount (2023) |
|---|---|---|
| Cash and Cash Equivalents | $51.0 million | $80.8 million |
| Outstanding Revolving Credit | $20.0 million | $20.0 million |
INNOVATE Corp. (VATE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- INNOVATE Corp. (VATE) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of INNOVATE Corp. (VATE)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View INNOVATE Corp. (VATE)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.